PROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.

Shaun G. Goodman, A. Langer, Iqbal Bata et al.|PubMed|1996

Cited by 3